Pharmafile Logo
Pharmafocus logo
Advanced Search
imbruv_pack

Janssen reveals positive results from longest follow-up of Imbruvica

December 7, 2016
Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica

Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …

News
jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016
Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

News

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016
Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …

News
astrazeneca_sign_sky

AZ lung cancer drug cuts disease progression by 70%

December 7, 2016
Research and Development AstraZeneca, Tagrisso

AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …

News
veeva_commercial_summit

Veeva releases key details from European Life Sciences Survey

December 6, 2016
veeva

Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …

News
shire_image

Shire given permission for $400 million biologics manufacturing facility

December 6, 2016
Manufacturing and Production, Research and Development Co Meat, Ireland, Shire

Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …

News
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …

Appointment
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

Appointment
gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016
Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …

News
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

News
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …

Appointment
merck_kapa_biosystems

Merck and Roche extend distribution ties

December 5, 2016
Manufacturing and Production Merck, Roche, distribution

Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …

News
entrance_takeda_i020_v1

Takeda to invest €40m in Dublin operations expansion

December 5, 2016
Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda

Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …

News

Mission Therapeutics announces new non-executive chairman

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …

Appointment
interactions-carousel

Scientists create ‘map of drugs’ to aid further development

December 5, 2016
Manufacturing and Production, Medical Communications

Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …

News
veeva_commercial_summit

Veeva announces Veeva CRM Engage Meeting at European Commercial Summit

December 5, 2016
Medical Communications Big Data, CRM, veeva

Veeva, a cloud software company, concluded its annual European Commercial Summit last week, held this year in Madrid. The conference …

News

FDA approves another indication for Lilly/Boehringer diabetes treatment

December 5, 2016
Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance

Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …

News
hands-coffee-smartphone-technology_smaller

Technology and patient adherence: Putting control of medication directly in patients’ hands

December 5, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology

Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …

Feature
reneuron

ReNeuron’s stem cell therapy improves motor function in stroke study

December 5, 2016
Research and Development ReNeuron, stem cell, stem cell therapy, stroke

ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …

News

Ablynx secures first €1m milestone payment from Novo Nordisk

December 5, 2016
Sales and Marketing Ablynx, Novo Nordisk, nanobody

Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026